US OptionsDetailed Quotes
PFE240719P30500
- 0.71
- +0.11+18.33%
15min DelayTrading Jul 18 15:05 ET
0.71High0.14Low
0.43Open0.60Pre Close3.23K Volume155 Open Interest30.50Strike Price89.85KTurnover34.00%IV-0.22%PremiumJul 19, 2024Expiry Date0.78Intrinsic Value100Multiplier1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.8857Delta0.3165Gamma33.97Leverage Ratio-0.0295Theta-0.0008Rho-30.09Eff Leverage0.0035Vega
Pfizer Stock Discussion
“Be Fearful When Others Are Greedy and Greedy When Others Are Fearful” – Warren Buffett
“Success means being very patient, but aggressive when it’s time.” – Charlie Munger
My previous posts,
I am looking forward to upcoming Fed cuts
Will Nvidia Pullback to 90 ?
$NVIDIA(NVDA.US)$ $iShares Russell 2000 ETF(IWM.US)$ $MarketAxess(MKTX.US)$ $Pfizer(PFE.US)$ $Vanguard Real Estate ETF(VNQ.US)$ $Global Payments(GPN.US)$
loading...
The P2 data they published in obese, non-diabetics doesn't look too good. Danuglipron twice daily compared with $Eli Lilly and Co(LLY.US)$ Orforglipron and $Structure Therapeutics(GPCR.US)$ GSBR 1290 at week 12: Orforglipron seems to be the best non-peptide GLP-1 RA
AI stocks may be struggling in short term but fundamentals are still very strong. A little pullback is normal.
loading...
Gapping up
$Costco(COST.US)$ shares saw an increase of nearly 1.34% as the company announced its first membership fee increase since 2017, raising the cost of its annual membership in the U.S. and Canada by $5 and its higher-tier plan by $10.
$Pfizer(PFE.US)$ 's stock went up nearly 2.8% following the company's announcement that it will proceed with the development of a once-daily version of its weight loss pill, ...
According to Zhittong Finance, Pfizer announced on Tuesday that Mikael Dolsten, its Chief Scientific Officer and R&D President, will leave the company after more than 15 years of service. The New York-based pharmaceutical giant said it would launch a months-long external recruitment program to identify a new Chief Scientific Officer, a move expected to last until early next year. The company said, "Dolsten will assist in job search and continue in his current role until his s...
No comment yet